Complement expression on astrocytes and astrocytoma cell lines: failure of complement regulation at the C3 level correlates with very low CD55 expression
- PMID: 8982108
- DOI: 10.1016/s0165-5728(96)00136-1
Complement expression on astrocytes and astrocytoma cell lines: failure of complement regulation at the C3 level correlates with very low CD55 expression
Abstract
Primary fetal human astrocytes and an astrocytoma cell line, U373-MG, expressed membrane cofactor protein (CD46), CD59, and low levels of decay-accelerating factor (CD55). Astrocyte CD55 was capable of regulating C3 deposition on the cell surface; albeit at a lower level than primary human fibroblasts. Negligible complement-mediated lysis of primary astrocytes and the U373-MG cell line was observed, even when large amount of astrocyte-specific, complement-activating antibodies were bound to the cells. Blocking the function of CD59 on astrocytes resulted in a > 90% cell lysis, while equivalent lysis of fibroblasts could only be achieved with additional blocking of CD55.
Similar articles
-
Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.Eur J Cancer. 1999 Jan;35(1):117-24. doi: 10.1016/s0959-8049(98)00290-1. Eur J Cancer. 1999. PMID: 10211099
-
Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.J Neurochem. 1996 Jan;66(1):303-12. doi: 10.1046/j.1471-4159.1996.66010303.x. J Neurochem. 1996. PMID: 8522968
-
Cytokines affect resistance of human renal tumour cells to complement-mediated injury.Scand J Immunol. 2003 Jun;57(6):591-9. doi: 10.1046/j.1365-3083.2003.01265.x. Scand J Immunol. 2003. PMID: 12791098
-
Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors.Mol Immunol. 2003 Sep;40(2-4):109-23. doi: 10.1016/s0161-5890(03)00112-3. Mol Immunol. 2003. PMID: 12914817 Review.
-
[The role of membrane glycoproteins CD46, CD55 and CD59 in protection of tumor cells against complement lysis].Postepy Hig Med Dosw. 2002;56(5):603-16. Postepy Hig Med Dosw. 2002. PMID: 12587428 Review. Polish.
Cited by
-
AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance.Nat Rev Neurol. 2010 Jul;6(7):383-92. doi: 10.1038/nrneurol.2010.72. Nat Rev Neurol. 2010. PMID: 20639914 Review.
-
Receptors and Host Factors for Enterovirus Infection: Implications for Cancer Therapy.Cancers (Basel). 2024 Sep 12;16(18):3139. doi: 10.3390/cancers16183139. Cancers (Basel). 2024. PMID: 39335111 Free PMC article. Review.
-
Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G.J Neuroinflammation. 2014 Jan 27;11:16. doi: 10.1186/1742-2094-11-16. J Neuroinflammation. 2014. PMID: 24468108 Free PMC article.
-
Classical Complement Pathway Inhibition in a "Human-On-A-Chip" Model of Autoimmune Demyelinating Neuropathies.Adv Ther (Weinh). 2022 Jun;5(6):2200030. doi: 10.1002/adtp.202200030. Epub 2022 Apr 5. Adv Ther (Weinh). 2022. PMID: 36211621 Free PMC article.
-
Roles of the complement system in human neurodegenerative disorders: pro-inflammatory and tissue remodeling activities.Mol Neurobiol. 2002 Feb;25(1):1-17. doi: 10.1385/mn:25:1:001. Mol Neurobiol. 2002. PMID: 11890454 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous